UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

British journal of cancer, 2008-09, Vol.99 (6), p.923-929

2008

Volltextzugriff (PDF)

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

British journal of cancer, 2014-10, Vol.111 (9), p.1757-1764

2014

Volltextzugriff (PDF)

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

British journal of cancer, 2012-12, Vol.107 (12), p.1932-1937

2012

Volltextzugriff (PDF)

P-028Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii9-ii9

2016

Volltextzugriff (PDF)

'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

British journal of cancer, 2007-12, Vol.97 (11), p.1560-1566

2007

Volltextzugriff (PDF)

Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors

Clinical & translational oncology, 2018-02, Vol.20 (2), p.140-149

2018

Volltextzugriff (PDF)

1233P Genomic scarring score as a criterion for PARP inhibitor administration in early-stage NSCLC

Annals of oncology, 2024-09, Vol.35, p.S791-S791

2024

Volltextzugriff (PDF)

1277P HRD status of patients with early stage non-small cell lung cancer

Annals of oncology, 2023-10, Vol.34, p.S737-S738

2023

Volltextzugriff (PDF)

EP.03B.01 The Genomic Scarring Score as a Biomarker for the Use of PARP Inhibitors in Early-Stage Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S447-S447

2024

Volltextzugriff (PDF)

Affective Architectures: More-Than-Representational Geographies of Heritage

1st, 2021

Volltextzugriff (PDF)

14P Studying tumour heterogeneity of primary non-small cell lung cancer in humans and mice (PDX)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S704-S705

2021

Volltextzugriff (PDF)

Next generation sequencing identifies actionable mutations in EGFR-wild type and KRAS mutant non-small cell lung cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi433-vi433

2016

Volltextzugriff (PDF)

P-028 Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)

Annals of oncology, 2016-06, Vol.27, p.ii9

2016

Volltextzugriff (PDF)

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer

Translational oncology, 2017-08, Vol.10 (4), p.693-698

2017

Volltextzugriff (PDF)

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer1

Translational oncology, 2017-08, Vol.10 (4), p.693-698

2017

Volltextzugriff (PDF)

P15 BRCA1 mRNA expression levels are associated with clinical responses to front-line docetaxel/gemcitabine in patients with lung adenocarcinomas in an expanded multicentre phase II study

European journal of cancer supplements, 2007, Vol.5 (8), p.33-33

2007

Volltextzugriff (PDF)

Association of PIK3CA kinase domain mutations with poor prognosis in operable breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21060-e21060

2011

Volltextzugriff (PDF)

Effect of epidural volume extension after subarachnoid administration of isobaric bupivacaine, ropivacaine and levo-bupivacaine with fentanyl in pregnant women undergoing C-section: 11AP2-9

European journal of anaesthesiology, 2013-06, Vol.30, p.171-171

2013

Volltextzugriff (PDF)

P17 EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC)

European journal of cancer supplements, 2007, Vol.5 (8), p.35-35

2007

Volltextzugriff (PDF)

Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non- small cell lung cancer (NSCLC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18062-18062

2007

Volltextzugriff (PDF)

P3-156: Different EGFR mutation patterns are associated with survival and response to first-line chemotherapy in NSCLC

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S746-S746

2007

Volltextzugriff (PDF)

P2-201: Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S650-S651

2007

Volltextzugriff (PDF)

P3-157: Correlation of EGFR mutation status between primary tumor and metastases in NSCLC

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S746-S746

2007

Volltextzugriff (PDF)

Sequence divergence of the RNA polymerase shared subunit ABC14.5 (Rpb8) selectively affects RNA polymerase III assembly in Saccharomyces cerevisiae

Nucleic acids research, 1999-02, Vol.27 (4), p.1047-1055

1999

Volltextzugriff (PDF)

TOLERANCE OF A LASER REFLECTORLESS EDM INSTRUMENT

Survey review - Directorate of Overseas Surveys, 2007-10, Vol.39 (306), p.308-315

2007

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(125)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(144)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(40)
Humans
(30)
Oncology
(23)
Female
(21)
Social Sciences
(20)
Male
(19)
Adult
(17)
Middle Aged
(17)
Education & Educational Research
(16)
Mathematics Education
(16)
Aged
(14)
Tumors
(14)
Education
(11)
Mutation
(11)
Prognosis
(11)
Biological And Medical Sciences
(10)
Children
(10)
Medical Sciences
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

P-028Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)

'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors

1233P Genomic scarring score as a criterion for PARP inhibitor administration in early-stage NSCLC

1277P HRD status of patients with early stage non-small cell lung cancer

EP.03B.01 The Genomic Scarring Score as a Biomarker for the Use of PARP Inhibitors in Early-Stage Non-Small Cell Lung Cancer

Affective Architectures: More-Than-Representational Geographies of Heritage

14P Studying tumour heterogeneity of primary non-small cell lung cancer in humans and mice (PDX)

Next generation sequencing identifies actionable mutations in EGFR-wild type and KRAS mutant non-small cell lung cancer patients

P-028 Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer1

P15 BRCA1 mRNA expression levels are associated with clinical responses to front-line docetaxel/gemcitabine in patients with lung adenocarcinomas in an expanded multicentre phase II study

Association of PIK3CA kinase domain mutations with poor prognosis in operable breast cancer

Effect of epidural volume extension after subarachnoid administration of isobaric bupivacaine, ropivacaine and levo-bupivacaine with fentanyl in pregnant women undergoing C-section: 11AP2-9

P17 EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC)

Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non- small cell lung cancer (NSCLC)

P3-156: Different EGFR mutation patterns are associated with survival and response to first-line chemotherapy in NSCLC

P2-201: Correlation of gefitinib efficacy and detection of new EGFR mutation variants in pre-treated patients (pts) with advanced non-small cell lung cancer (NSCLC)

P3-157: Correlation of EGFR mutation status between primary tumor and metastases in NSCLC

Sequence divergence of the RNA polymerase shared subunit ABC14.5 (Rpb8) selectively affects RNA polymerase III assembly in Saccharomyces cerevisiae

TOLERANCE OF A LASER REFLECTORLESS EDM INSTRUMENT

Suchergebnisse filtern